The introduction of a RUNX1 mutant into miR‐146a‐deficient HSPCs induces AML, highlighting a synergistic interaction between dysregulated innate immune signaling and RUNX1 mutations. This evidence concerns the gene RUNX1 and acute myeloid leukemia.